Your search for major depressive disorder returned 3 results

Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.

The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to targeted areas of the brain.